>>SOUTH SAN FRANCISCO, Calif., Jan. 12 /PRNewswire-FirstCall/ -- CoTherix, Inc. (Nasdaq: CTRX - News) today announced that it has filed a registration statement with the Securities and Exchange Commission covering a proposed offering of 4,000,000 shares of its common stock. All of the shares will be offered by CoTherix. The company intends to grant the underwriters the option to purchase up to an additional 600,000 shares of common stock to cover over-allotments, if any. CIBC World Markets Corp. and Piper Jaffray & Co. will act as joint book-running managers, and Needham & Company, Inc. and Thomas Weisel Partners LLC will act as co-managers of the offering.
The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the offering may be obtained from CIBC World Markets Corp., by email at useprospectus@us.cibc.com or by fax at 212/ 667-6136 and from Piper Jaffray & Co., U.S. Bancorp Center, 800 Nicollet Mall, Minneapolis, Minnesota 55402.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.<<
snip
This ended up being priced at $8.90, and the over-allotment was partially exercised, to the tune of 250,000 shares. However, they haven't commenced the CTX-100 trial. Perhaps because of the smaller than hoped for IPO? In which case, this follow-on is likely intended to get CTX-100 going?
Cheers, Tuck |
